DCM
MRNA icon

Dupont Capital Management’s Moderna MRNA Stock Holding History

Dupont Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-72
Closed -$11.1K – 675
2023
Q1 		$11.1K Sell
72
-2,215
-97% -$365K ﹤0.01% 566
2022
Q4 		$411K Sell
2,287
-211
-8% -$34.5K 0.02% 607
2022
Q3 		$295K Sell
2,498
-435
-15% -$66K 0.02% 766
2022
Q2 		$419K Sell
2,933
-334
-10% -$47.7K 0.02% 778
2022
Q1 		$563K Sell
3,267
-1,509
-32% -$254K 0.02% 703
2021
Q4 		$1.21M Sell
4,776
-4,306
-47% -$1.26M 0.04% 443
2021
Q3 		$3.5M Buy
9,082
+3,418
+60% +$1.26M 0.11% 187
2021
Q2 		$1.33M Buy
+5,664
New +$1.01M 0.03% 487
2020
Q4 		– Sell
-4,458
Closed -$315K – 1367
2020
Q3 		$315K Buy
+4,458
New +$311K 0.01% 953

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dupont Capital Management's MRNA Position: Q2 2023 in Review

Dupont Capital Management sold out of Moderna (MRNA) in Q2 2023, closing a stake of 72 shares — an estimated $11.1K sold.

Dupont Capital Management first reported a position in MRNA in Q3 2020 and held it in 9 quarters. The position peaked at $3.5M in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Dupont Capital Management reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Dupont Capital Management sold 72 Moderna shares in Q2 2023, an estimated $11.1K.
  • Dupont Capital Management first reported a position in Moderna in Q3 2020 and held it in 9 quarters.
  • Dupont Capital Management's Moderna position peaked at $3.5M in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Dupont Capital Management's 13F filing for Q2 2023, filed 25 Jul 2023.